R3vive vs The Joint Chiropractic
Franchise Comparison 2026
FDDs: R3vive 2022, The Joint Chiropractic 2025SBA 7(a) data through FY2026Updated How we score
Not like-for-like: these figures come from FDDs of different years (2022, 2025). Costs, fees and unit counts change from one filing to the next, so the older column may be out of date.
Both R3vive and The Joint Chiropractic are franchises in the healthcare category. R3vive requires an investment of $262K – $669K while The Joint Chiropractic requires $245K – $543K. The Joint Chiropractic discloses average gross sales of $570K; R3vive makes no financial performance representation in its Item 19, which is voluntary under the FTC Franchise Rule. The Joint Chiropractic has SBA lending data on file with a 3.7% charge-off rate. FranchiseVerdict rates R3vive B (Second tier) and The Joint Chiropractic A (Strongest tier).
| Metric | R3vive | The Joint Chiropractic |
|---|---|---|
| Verdict Grade | ||
| Investment Range | $262K – $669K | $245K – $543K |
| Franchise Fee | $75K | $40K |
| Royalty Rate | 6.0% | 7.0% |
| Average Gross Sales (Item 19) | N/ANot disclosed | $570K |
| SBA Charge-Off Rate | N/A | 3.7% (81 resolved loans) |
| Total Units | 10 | 970 |
| Unit Growth (YoY) | +2 units | +45 units |
| Year Began Franchising | 2020 | 2010 |
| FDD Year | 2022 | 2025 |
Next step
Browse free
Every brand with an FDD on file, graded, with costs, disclosed sales and SBA records. No sign-in.Pro
For advisors and lenders working across many brands; inquire by email.